The global market for Edaravone was valued at US$ 1071 million in the year 2024 and is projected to reach a revised size of US$ 1461 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Edaravone Market

North American market for Edaravone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Edaravone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Edaravone include Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd, Piramal Healthcare, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Edaravone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone.

The Edaravone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Edaravone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Edaravone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Edaravone Market Report

Report Metric	Details
Report Name	Edaravone Market
Accounted market size in year	US$ 1071 million
Forecasted market size in 2031	US$ 1461 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Edaravone Injection Edaravone
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd, Piramal Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Edaravone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Edaravone Market growing?

Ans: The Edaravone Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Edaravone Market size in 2031?

Ans: The Edaravone Market size in 2031 will be US$ 1461 million.

Who are the main players in the Edaravone Market report?

Ans: The main players in the Edaravone Market are Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd, Piramal Healthcare

What are the Application segmentation covered in the Edaravone Market report?

Ans: The Applications covered in the Edaravone Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Edaravone Market report?

Ans: The Types covered in the Edaravone Market report are Oral Edaravone, Injection Edaravone

1 Edaravone Market Overview

1.1 Product Definition

1.2 Edaravone by Type

1.2.1 Global Edaravone Market Value Comparison by Type (2024 VS 2031)

1.2.2 Oral Edaravone

1.2.3 Injection Edaravone

1.3 Edaravone by Application

1.3.1 Global Edaravone Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Edaravone Market Size Estimates and Forecasts

1.4.1 Global Edaravone Revenue 2020-2031

1.4.2 Global Edaravone Sales 2020-2031

1.4.3 Global Edaravone Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Edaravone Market Competition by Manufacturers

2.1 Global Edaravone Sales Market Share by Manufacturers (2020-2025)

2.2 Global Edaravone Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Edaravone Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Edaravone, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Edaravone, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Edaravone, Product Type & Application

2.7 Global Key Manufacturers of Edaravone, Date of Enter into This Industry

2.8 Global Edaravone Market Competitive Situation and Trends

2.8.1 Global Edaravone Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Edaravone Players Market Share by Revenue

2.8.3 Global Edaravone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Edaravone Market Scenario by Region

3.1 Global Edaravone Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Edaravone Sales by Region: 2020-2031

3.2.1 Global Edaravone Sales by Region: 2020-2025

3.2.2 Global Edaravone Sales by Region: 2026-2031

3.3 Global Edaravone Revenue by Region: 2020-2031

3.3.1 Global Edaravone Revenue by Region: 2020-2025

3.3.2 Global Edaravone Revenue by Region: 2026-2031

3.4 North America Edaravone Market Facts & Figures by Country

3.4.1 North America Edaravone Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Edaravone Sales by Country (2020-2031)

3.4.3 North America Edaravone Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Edaravone Market Facts & Figures by Country

3.5.1 Europe Edaravone Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Edaravone Sales by Country (2020-2031)

3.5.3 Europe Edaravone Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Edaravone Market Facts & Figures by Region

3.6.1 Asia Pacific Edaravone Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Edaravone Sales by Region (2020-2031)

3.6.3 Asia Pacific Edaravone Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Edaravone Market Facts & Figures by Country

3.7.1 Latin America Edaravone Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Edaravone Sales by Country (2020-2031)

3.7.3 Latin America Edaravone Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Edaravone Market Facts & Figures by Country

3.8.1 Middle East and Africa Edaravone Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Edaravone Sales by Country (2020-2031)

3.8.3 Middle East and Africa Edaravone Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Edaravone Sales by Type (2020-2031)

4.1.1 Global Edaravone Sales by Type (2020-2025)

4.1.2 Global Edaravone Sales by Type (2026-2031)

4.1.3 Global Edaravone Sales Market Share by Type (2020-2031)

4.2 Global Edaravone Revenue by Type (2020-2031)

4.2.1 Global Edaravone Revenue by Type (2020-2025)

4.2.2 Global Edaravone Revenue by Type (2026-2031)

4.2.3 Global Edaravone Revenue Market Share by Type (2020-2031)

4.3 Global Edaravone Price by Type (2020-2031)

5 Segment by Application

5.1 Global Edaravone Sales by Application (2020-2031)

5.1.1 Global Edaravone Sales by Application (2020-2025)

5.1.2 Global Edaravone Sales by Application (2026-2031)

5.1.3 Global Edaravone Sales Market Share by Application (2020-2031)

5.2 Global Edaravone Revenue by Application (2020-2031)

5.2.1 Global Edaravone Revenue by Application (2020-2025)

5.2.2 Global Edaravone Revenue by Application (2026-2031)

5.2.3 Global Edaravone Revenue Market Share by Application (2020-2031)

5.3 Global Edaravone Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Mitsubishi Tanabe Pharma

6.1.1 Mitsubishi Tanabe Pharma Company Information

6.1.2 Mitsubishi Tanabe Pharma Description and Business Overview

6.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Mitsubishi Tanabe Pharma Edaravone Product Portfolio

6.1.5 Mitsubishi Tanabe Pharma Recent Developments/Updates

6.2 Simcere

6.2.1 Simcere Company Information

6.2.2 Simcere Description and Business Overview

6.2.3 Simcere Edaravone Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Simcere Edaravone Product Portfolio

6.2.5 Simcere Recent Developments/Updates

6.3 Taj Pharmaceuticals Ltd.

6.3.1 Taj Pharmaceuticals Ltd. Company Information

6.3.2 Taj Pharmaceuticals Ltd. Description and Business Overview

6.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Taj Pharmaceuticals Ltd. Edaravone Product Portfolio

6.3.5 Taj Pharmaceuticals Ltd. Recent Developments/Updates

6.4 Sun Pharmaceutical Industries Ltd.

6.4.1 Sun Pharmaceutical Industries Ltd. Company Information

6.4.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview

6.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio

6.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates

6.5 Unichem Laboratories Ltd

6.5.1 Unichem Laboratories Ltd Company Information

6.5.2 Unichem Laboratories Ltd Description and Business Overview

6.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Unichem Laboratories Ltd Edaravone Product Portfolio

6.5.5 Unichem Laboratories Ltd Recent Developments/Updates

6.6 UCB India Ltd

6.6.1 UCB India Ltd Company Information

6.6.2 UCB India Ltd Description and Business Overview

6.6.3 UCB India Ltd Edaravone Sales, Revenue and Gross Margin (2020-2025)

6.6.4 UCB India Ltd Edaravone Product Portfolio

6.6.5 UCB India Ltd Recent Developments/Updates

6.7 Piramal Healthcare

6.7.1 Piramal Healthcare Company Information

6.7.2 Piramal Healthcare Description and Business Overview

6.7.3 Piramal Healthcare Edaravone Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Piramal Healthcare Edaravone Product Portfolio

6.7.5 Piramal Healthcare Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Edaravone Industry Chain Analysis

7.2 Edaravone Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Edaravone Production Mode & Process Analysis

7.4 Edaravone Sales and Marketing

7.4.1 Edaravone Sales Channels

7.4.2 Edaravone Distributors

7.5 Edaravone Customer Analysis

8 Edaravone Market Dynamics

8.1 Edaravone Industry Trends

8.2 Edaravone Market Drivers

8.3 Edaravone Market Challenges

8.4 Edaravone Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Mitsubishi Tanabe Pharma

Simcere

Taj Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Unichem Laboratories Ltd

UCB India Ltd

Piramal Healthcare

List of Tables

Table 1. Global Edaravone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Edaravone Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Edaravone Market Competitive Situation by Manufacturers in 2024

Table 4. Global Edaravone Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Edaravone Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Edaravone Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Edaravone Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Edaravone Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Edaravone, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Edaravone, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Edaravone, Product Type & Application

Table 12. Global Key Manufacturers of Edaravone, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Edaravone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edaravone as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Edaravone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Edaravone Sales by Region (2020-2025) & (K Units)

Table 18. Global Edaravone Sales Market Share by Region (2020-2025)

Table 19. Global Edaravone Sales by Region (2026-2031) & (K Units)

Table 20. Global Edaravone Sales Market Share by Region (2026-2031)

Table 21. Global Edaravone Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Edaravone Revenue Market Share by Region (2020-2025)

Table 23. Global Edaravone Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Edaravone Revenue Market Share by Region (2026-2031)

Table 25. North America Edaravone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Edaravone Sales by Country (2020-2025) & (K Units)

Table 27. North America Edaravone Sales by Country (2026-2031) & (K Units)

Table 28. North America Edaravone Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Edaravone Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Edaravone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Edaravone Sales by Country (2020-2025) & (K Units)

Table 32. Europe Edaravone Sales by Country (2026-2031) & (K Units)

Table 33. Europe Edaravone Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Edaravone Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Edaravone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Edaravone Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Edaravone Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Edaravone Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Edaravone Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Edaravone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Edaravone Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Edaravone Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Edaravone Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Edaravone Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Edaravone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Edaravone Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Edaravone Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Edaravone Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Edaravone Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Edaravone Sales (K Units) by Type (2020-2025)

Table 51. Global Edaravone Sales (K Units) by Type (2026-2031)

Table 52. Global Edaravone Sales Market Share by Type (2020-2025)

Table 53. Global Edaravone Sales Market Share by Type (2026-2031)

Table 54. Global Edaravone Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Edaravone Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Edaravone Revenue Market Share by Type (2020-2025)

Table 57. Global Edaravone Revenue Market Share by Type (2026-2031)

Table 58. Global Edaravone Price (USD/Unit) by Type (2020-2025)

Table 59. Global Edaravone Price (USD/Unit) by Type (2026-2031)

Table 60. Global Edaravone Sales (K Units) by Application (2020-2025)

Table 61. Global Edaravone Sales (K Units) by Application (2026-2031)

Table 62. Global Edaravone Sales Market Share by Application (2020-2025)

Table 63. Global Edaravone Sales Market Share by Application (2026-2031)

Table 64. Global Edaravone Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Edaravone Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Edaravone Revenue Market Share by Application (2020-2025)

Table 67. Global Edaravone Revenue Market Share by Application (2026-2031)

Table 68. Global Edaravone Price (USD/Unit) by Application (2020-2025)

Table 69. Global Edaravone Price (USD/Unit) by Application (2026-2031)

Table 70. Mitsubishi Tanabe Pharma Company Information

Table 71. Mitsubishi Tanabe Pharma Description and Business Overview

Table 72. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Mitsubishi Tanabe Pharma Edaravone Product

Table 74. Mitsubishi Tanabe Pharma Recent Developments/Updates

Table 75. Simcere Company Information

Table 76. Simcere Description and Business Overview

Table 77. Simcere Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Simcere Edaravone Product

Table 79. Simcere Recent Developments/Updates

Table 80. Taj Pharmaceuticals Ltd. Company Information

Table 81. Taj Pharmaceuticals Ltd. Description and Business Overview

Table 82. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Taj Pharmaceuticals Ltd. Edaravone Product

Table 84. Taj Pharmaceuticals Ltd. Recent Developments/Updates

Table 85. Sun Pharmaceutical Industries Ltd. Company Information

Table 86. Sun Pharmaceutical Industries Ltd. Description and Business Overview

Table 87. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Sun Pharmaceutical Industries Ltd. Edaravone Product

Table 89. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 90. Unichem Laboratories Ltd Company Information

Table 91. Unichem Laboratories Ltd Description and Business Overview

Table 92. Unichem Laboratories Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Unichem Laboratories Ltd Edaravone Product

Table 94. Unichem Laboratories Ltd Recent Developments/Updates

Table 95. UCB India Ltd Company Information

Table 96. UCB India Ltd Description and Business Overview

Table 97. UCB India Ltd Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. UCB India Ltd Edaravone Product

Table 99. UCB India Ltd Recent Developments/Updates

Table 100. Piramal Healthcare Company Information

Table 101. Piramal Healthcare Description and Business Overview

Table 102. Piramal Healthcare Edaravone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Piramal Healthcare Edaravone Product

Table 104. Piramal Healthcare Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Edaravone Distributors List

Table 108. Edaravone Customers List

Table 109. Edaravone Market Trends

Table 110. Edaravone Market Drivers

Table 111. Edaravone Market Challenges

Table 112. Edaravone Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Edaravone

Figure 2. Global Edaravone Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Edaravone Market Share by Type: 2024 & 2031

Figure 4. Oral Edaravone Product Picture

Figure 5. Injection Edaravone Product Picture

Figure 6. Global Edaravone Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Edaravone Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Edaravone Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Edaravone Market Size (2020-2031) & (US$ Million)

Figure 13. Global Edaravone Sales (2020-2031) & (K Units)

Figure 14. Global Edaravone Average Price (USD/Unit) & (2020-2031)

Figure 15. Edaravone Report Years Considered

Figure 16. Edaravone Sales Share by Manufacturers in 2024

Figure 17. Global Edaravone Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Edaravone Players: Market Share by Revenue in Edaravone in 2024

Figure 19. Edaravone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Edaravone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Edaravone Sales Market Share by Country (2020-2031)

Figure 22. North America Edaravone Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Edaravone Sales Market Share by Country (2020-2031)

Figure 26. Europe Edaravone Revenue Market Share by Country (2020-2031)

Figure 27. Germany Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Edaravone Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Edaravone Revenue Market Share by Region (2020-2031)

Figure 34. China Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Edaravone Sales Market Share by Country (2020-2031)

Figure 44. Latin America Edaravone Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Edaravone Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Edaravone Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Edaravone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Edaravone by Type (2020-2031)

Figure 54. Global Revenue Market Share of Edaravone by Type (2020-2031)

Figure 55. Global Edaravone Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Edaravone by Application (2020-2031)

Figure 57. Global Revenue Market Share of Edaravone by Application (2020-2031)

Figure 58. Global Edaravone Price (USD/Unit) by Application (2020-2031)

Figure 59. Edaravone Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Edaravone Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-19P8266

Global Edaravone Market Research Report 2025

FEATURED COMPANIES

Edaravone Market Size

Edaravone Market

Report Scope

Scope of Edaravone Market Report

Core Chapters

FAQ for this report

How fast is Edaravone Market growing?

What is the Edaravone Market size in 2031?

Who are the main players in the Edaravone Market report?

What are the Application segmentation covered in the Edaravone Market report?

What are the Type segmentation covered in the Edaravone Market report?

FEATURED COMPANIES

RELATED REPORTS

Global Food Additives Market Insights and Forecast to 2028

Single User, Electronic (PDF)